ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

VIR Vir Biotechnology Inc

9,06
0,32 (3,66%)
Zuletzt aktualisiert: 19:46:35
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Vir Biotechnology Inc VIR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,32 3,66% 9,06 19:46:35
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,91 8,745 9,155 8,74
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:05BWVir Biotechnology to Participate in the BofA Securities..
18.4.202414:00BWVir Biotechnology Announces Nomination of Norbert..
11.4.202422:30BWVir Biotechnology to Provide Business Update and Report..
05.3.202414:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
27.2.202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
26.2.202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23.2.202414:05BWVir Biotechnology to Participate in Upcoming Investor..
22.2.202422:12EDGAR2Form 8-K - Current report
22.2.202422:05BWVir Biotechnology Provides Corporate Update and Reports..
20.2.202422:33EDGAR2Form 8-K - Current report
20.2.202422:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
17.2.202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202422:05BWVir Biotechnology to Provide Business Update and Report..
03.1.202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202311:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
13.12.202322:06EDGAR2Form 8-K - Current report
13.12.202322:05BWVir Biotechnology Announces Strategic Steps to Reduce..
06.12.202322:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
13.11.202314:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
10.11.202314:00BWVir Biotechnology to Present Late-Breaking Data from Its..
08.11.202314:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
03.11.202321:37EDGAR2Form 8-K - Current report
03.11.202321:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03.11.202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:09EDGAR2Form 8-K - Current report
02.11.202321:05BWVir Biotechnology Provides Corporate Update and Reports..
30.10.202313:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
12.10.202322:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11.10.202314:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
05.10.202322:30GLOBEVir Biotechnology to Provide Business Update and Report..
03.10.202314:01EDGAR2Form 8-K - Current report
03.10.202313:59GLOBEVir Biotechnology Awarded BARDA Funding to Support..
20.9.202314:00GLOBEVir Biotechnology Announces First Participant Dosed in New..
20.9.202312:02EDGAR2Form 8-K - Current report
29.8.202322:30GLOBEVir Biotechnology to Participate in Upcoming Investor..
04.8.202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:14EDGAR2Form 8-K - Current report
03.8.202322:05GLOBEVir Biotechnology Provides Corporate Update and Reports..
26.7.202322:05GLOBEVir Biotechnology to Provide Business Update and Report..
20.7.202314:04EDGAR2Form 8-K - Current report
20.7.202314:00GLOBEVir Biotechnology Announces Topline Data from Phase 2..
06.7.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.7.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202323:01EDGAR2Form 144 - Report of proposed sale of securities
29.6.202315:00GLOBEVir Biotechnology Appoints Sasha Damouni Ellis as Executive..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock